Fatima Gulzar
- Indexed articles, last 90 days
- 378
- Latest publication
- Sep 29, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 7, 2026
Latest articles
Is CEO Jensen Huang Becoming Nvidia (NVDA)’s Most Valuable Political Asset? (opens the original)
Read excerpt
CEO of Nvidia, Jensen Huang’s influence in Washington has become one of Nvidia’s more unusual competitive assets. Late September 2026 brought confirmation of just how close that relationship has become, with Treasury Secretary Scott Bessent telling Congress that President Trump is “completely aligned” with Huang’s views on AI policy. The alignment follows Huang’s public pushback earlier in the month against calls from Anthropic’s Dario Amodei and OpenAI’s Sam Altman to slow AI development. Huang
Can Paramount (PSKY) Turn Warner Bros. (WBD) Scale Into Returns After its Regulatory Concessions? (opens the original)
Read excerpt
Paramount Skydance Corporation (NASDAQ:PSKY)’s $81 billion pursuit of Warner Bros. Discovery, Inc. (NASDAQ:WBD) cleared its biggest legal obstacle in late September 2026, when the company settled with California and 11 other states. The terms commit Paramount to at least $1.5 billion of additional U.S. production spending over five years, a minimum of 30 films released annually, keeping its Los Angeles studio lots, funding workforce training, and building editorial-independence safeguards for CN
Does Meta (META)’s Advertising Scale Make Brief Outages Financially Irrelevant? (opens the original)
Read excerpt
Outages at Meta Platforms, Inc. (NASDAQ:META)’s platforms don’t usually move the stock, but they do tend to raise the same question each time they recur. On September 20, Reuters reported that Facebook and Instagram went down for U.S. users for roughly an hour, starting around 8:55 p.m. Eastern, with Downdetector logging more than 17,000 Facebook reports and over 5,000 for Instagram at the peak before service returned by 10 p.m. It was the second notable disruption in a few months, following a s
Can Novo Nordisk (NVO) Find a Second Act Before its First One Fades? (opens the original)
Read excerpt
A stock that has lost more than 70% of its value from the peak tends to invite hard questions, and Novo Nordisk A/S (NYSE:NVO) is now facing them from its own investors. Late September 2026 brought renewed pressure on the company to explain what comes after its weight-loss drug franchise, as analysts project Eli Lilly’s Zepbound will outsell Novo’s Wegovy by more than $7 billion this year. Novo did raise its 2026 sales and profit growth guidance to a range of 0% to negative 6% at constant exchan
Does Caesars (CZR)’s $31 Buyout Offer Enough Reward for the Regulatory Wait? (opens the original)
Read excerpt
A billionaire hospitality magnate, Tilman Fertitta, cleared one hurdle in late September 2026 while running into another. The Federal Trade Commission issued a standard second request for more information, a step that can extend the regulatory timeline, right around the time Caesars Entertainment, Inc. (NASDAQ:CZR) shareholders voted decisively to approve the deal, with 65.4% of outstanding shares in favor on September 22. Fertitta intends to make Caesars a wholly owned subsidiary once regulator
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.